Global Acetazolamide Market Projected to Reach $271.69 Million by 2028: Driven by Growing Incidence of Glaucoma and Innovation in Production

DUBLIN, July 20, 2023 /PRNewswire/ -- The "Global Acetazolamide Market (2023-2028) by Formulation, Distribution Channel, Application, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Acetazolamide Market is estimated to be USD 201.12 Mn in 2023 and is expected to reach USD 271.69 Mn by 2028, growing at a CAGR of 6.20%.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Acetazolamide Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Acetazolamide Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Acetazolamide Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Market Dynamics:

Drivers

• Growing incidence of glaucoma
• High prevalence of eye disorders in the geriatric population

Restraints

• Concerns related to certain glitches during the production process

Opportunities

• Rising innovation in the production of varied types of acetazolamide

Challenges

• Technical and applications challenges in the evaluation of chronic cerebral ischemia

Companies Mentioned

• Accord Healthcare, Ltd.
• Avanscure Lifesciences Pvt. Ltd.
• Avet Pharmaceuticals, Inc.
• CTX Lifesciences Pvt. Ltd.
• Emcure Pharmaceuticals, Ltd.
• Heritage Pharmaceuticals, Inc.
• Lannett, Co. Inc.
• Manus Aktteva Biopharma LLP
• Mylan N.V.
• Nakoda Chemicals, Ltd.
• Nostrum Laboratories, Inc.
• Novast Laboratories Ltd.
• Ortin Laboratories Ltd.
• Strides Pharma Science, Ltd.
• Sun Pharmaceutical Industries, Ltd.
• Taro Pharmaceutical Industries, Ltd.
• Teva Pharmaceutical Industries Ltd.
• West-Ward Pharmaceuticals, Corp.
• X-Gen Pharmaceuticals, Inc.
• Zydus Pharmaceuticals (USA), Inc.

Market Segmentation

The Global Acetazolamide Market is segmented based on Formulation, Distribution Channel, Application, and Geography.

• By Formulation, the market is classified into Capsules, Injection, and Tablets.
• By Distribution Channel, the market is classified into Hospital, Online Drug Store, and Retail Drug Store.
• By Application, the market is classified into Glaucoma, Epilepsy, Drug Indicated Edema, Altitude Sickness, Fluid Retention, Heart Failures, and Seizures.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

For more information about this report visit https://www.researchandmarkets.com/r/gcqtsj

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected] 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets